NOVITIUM PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVITIUM PHARMA, and what generic alternatives to NOVITIUM PHARMA drugs are available?
NOVITIUM PHARMA has seventy-three approved drugs.
There is one US patent protecting NOVITIUM PHARMA drugs.
Summary for NOVITIUM PHARMA
| US Patents: | 1 |
| Tradenames: | 66 |
| Ingredients: | 65 |
| NDAs: | 73 |
Drugs and US Patents for NOVITIUM PHARMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | PREDNISONE | prednisone | TABLET;ORAL | 211575-001 | Nov 15, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | SUSPENSION;ORAL | 215003-001 | Sep 3, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 212260-001 | May 31, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 217696-001 | May 9, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 213730-003 | Dec 16, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | ESTRADIOL | estradiol | GEL;TRANSDERMAL | 217610-004 | Aug 24, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
